Seema Kumar

Dr Seema Kumar is a Director and Senior DMPK Lead at EMD Serono Inc, a business of Merck KGaA (Darmstadt, Germany). In her current role, Seema leads the Clinical Bioanalytical Sciences group that provides drug disposition support including bioanalysis, immunogenicity and DMPK support for clinical-stage NBE programs. Previously, Seema led the Regulated Bioanalytical Group at Pfizer (NY, USA), which provided regulated support for PK, ADA and Nab assays for pre-clinical and clinical programs. Prior to joining Pfizer, Seema served as Director of Quality Control and later as Director of the CLIA-certified Clinical Bioanalytical Lab at XBiotech Inc (TX, USA).

Seema holds a Ph.D. from Johns Hopkins University (MA, USA) and has several publications in peer-reviewed journals and has contributed to several book chapters. Dr. Kumar has given numerous talks at various national and international conferences and meetings and is an active member of industry consortia such as IQ, AAPS, etc.

What three things would you take if you were stranded on a desert island?
• A picture of my family (husband and kids)

If you weren’t a bioanalyst, what would you be?
• I have always wanted to be a medical doctor. Growing up, I admired doctors that treated patients and saved lives.

What is your favorite city?
• Venice. I love its scenic canals with intricate bridges, signature gondolas and impressive architecture.

Why have you decided to become a Zone Leader?

I have thoroughly enjoyed my affiliations and contributions to the Zone over the last few years and I am delighted to grasp the opportunity to build on that. It’s a great way of staying attuned to, and dynamically involved with, the bioanalytical community.